Ashraf Amanullah

About Ashraf Amanullah

Senior drug development and manufacturing executive with more than 24 years of demonstrated leadership experience in global and start-up pharma and biotechnology organizations. Experience in end to end CMC, technical operations, manufacturing, commercialization and life cycle management of antibody therapeutics, vaccines, viral vectors, cell-based therapeutics and recombinant proteins. Proven track record of leading and delivering on goals within key enterprise networks. Demonstrated ability to set and manage priorities, resources and performance targets. Energetic leader, adept at creating vision and building high-performing organizations that exceed expectations. Experienced in successfully leading end to end cross-functional teams of 100+ staff and holding strategic, value-based discussions with C-suite executives. Strong global network with industry and academic thought leaders.

Experience

1. EVP, Chief Technical Operations Officer

   Inhibrx Biosciences, Inc

   Sep 2020 — Present

   InhibRx (NASDAQ: INBX) is a clinical stage biologic therapeutic company focused on the treatment of oncology and inflammatory conditions. Inhibrx\'s proprietary single domain antibody technology platform allows the design of multispecific and multivalent molecules, and technologies to enable fit-for-function biotherapeutics that optimally interface with the biology of target antigens, focus immune activation and mediate enhanced signaling.

Education

• University of Birmingham

  Chemical Engineering

• University of Birmingham

  Ph.D., Biochemical Engineering

Skills

• Vaccines
• Technology Transfer
• Protein Chemistry
• Process Simulation
• Chromatography
• Lifesciences
• Biotechnology
• Formulation
• Pharmaceutical Industry
• Biopharmaceuticals
• Fda
• Cell
• Chemical Engineering
• Life Sciences
• Fermentation
• Gmp
• Cell Culture
• Validation
• Biochemistry